Results 91 to 100 of about 13,260 (225)
Systemic Transthyretin Amyloidosis Incidentally Diagnosed With Prostate Biopsy: A Case Report
IJU Case Reports, Volume 8, Issue 5, Page 503-507, September 2025.ABSTRACT Introduction The diagnosis of systemic transthyretin amyloidosis based on prostate biopsy is very rare, and we report this case with a literature review. Case Presentation A 73‐year‐old male patient was referred to our department due to an increased serum prostate‐specific antigen level at 10.4 ng/mL while receiving benign prostatic ...
Michihide Nakamura +14 more
wiley +1 more source
Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia; retrospective comparison between naftopidil and tamsulosin [PDF]
, 2005 前立腺肥大症88例を, 内服薬剤別に塩酸タムスロシン40例とナフトピジル48例で分け, 薬剤による射精障害の頻度及びQOLへの影響を比較検討した.その結果, 年齢及び投与期間と, 射精障害の有無による投与前後の排尿パラメーターに有意差は見られなかった.投与前の前立腺重量と残尿量と, 服用後の射精障害の頻度は塩酸タムスロシン群の方が高い傾向が見られたWe cross-sectionally studied the incidence and impact on quality of life of ...
久末, 伸一 +6 more
core
A stereoselective, catalytic strategy for the in-flow synthesis of advanced precursors of rasagiline and tamsulosin [PDF]
, 2017 The diastereoselective, trichlorosilane-mediate reduction of imines, bearing different and removable chiral auxiliaries, in combination either with achiral bases or catalytic amounts of chiral Lewis bases, was investigated to afford immediate precursors ...
Benaglia, Maurizio +4 more
core +2 more sources
Risks Associated with Drug Treatments for Kidney Stones [PDF]
, 2015 Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone ...
Borofsky, Michael S. +2 more
core +1 more source
Frontiers in Pharmacology, 2018 Background: Lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) is a common condition affecting men. Studies have shown that the prevalence of LUTS/BPH increases with age, which will cause considerable economic burden to ...
David Bin-Chia Wu +11 more
doaj +1 more source
International Journal of General Medicine, 2011 Sakineh Hajebrahimi1, Yadollah Ahmadi Asrbadr1, Arash Azaripour1, Homayoun Sadeghi-Bazargani2,31Urology Department, Imam Reza University Hospital, Tabriz, Iran; 2Neuroscience Research Center and RDCC, Tabriz University of Medical Sciences, Tabriz, Iran ...
Sakineh Hajebrahimi +3 more
doaj
15 - Tamsulosin in lower urinary tract dysfunctions of patients with Multiple Sclerosis
, 2023 Leonardo Martino +13 more
openalex +1 more source
The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men [PDF]
, 2016 BACKGROUND: Mirabegron is a β3-adrenoreceptor agonist developed for treatment of overactive bladder (OAB). α1-Adrenergic receptor blockers are effective for lower urinary tract symptoms (LUTS) in male patients.
Akihiro Asai +6 more
core +1 more source